{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Obstetrical and Gynecological Survey - Vol. 74, No. 12

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. CME Article 34: Preimplantation Genetic Testing for Aneuploidy: A Review -- Summarize the history of PGT-A, including the development over time of biopsy and analytical techniques; explain the continued uncertainty regarding the efficacy of PGT-A, and the associated safety concerns; and assess the impact mosaicism may have on the interpretation of PGT-A results and subsequent treatment recommendations
  2. CME Article 35: Associations Between Migraine and Adverse Pregnancy Outcomes: Systematic Review and Meta-analysis -- Describe the association between migraine and placenta-induced pregnancy complications; explain the possibility of the developing preeclampsia in women with a history of migraine; and assess the risk of preterm birth or a neonate with low birth weight or small for gestational age in women with migraine.
  3. CME Article 36: The Morcellation "Debate" and the FDA 510(k) Process--A Call for Further Reform -- Identify the challenges associated with the current 510(k) process; distinguish between the roles of the initial approval and post marketing surveillance of surgical products and their safety; and evaluate the efficacy of new surgical modalities and products.

Disclosures

All authors, faculty and staff in a position to control the content of this CME activity, and their spouses/life partners (if any), have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations relevant to this CME activity.

Price: $30.00

Credits:

  • ACCME 3.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 3.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planner
Professions: Physician
Test Code: OGS1219
Published: December 2109
Expires: 1/1/2026
Sources: Obstetrical & Gynecological Survey
Required Passing Score: 10/13 (76%)
Authors: James M. Kemper, MBBS(Hons), Beverley J. Vollenhoven, PhD, and Alon J. Talmor, PhD; Annet M. Aukes, MD, PhD, Feyza N. Yurtsever, BSc, Amélie Boutin, PhD, Marieke C. Visser, MD, PhD, and Christianne J. M. de Groot, MD, PhD; Lacey Brennan, MD, MBE, Magdy P. Milad, MD,MS, and Louise P. King, MD, JD
Categories: Gynecological , Obstetrical
Specialties: Gynecology, OB/GYN
Topics: Aneuploidy , Migraine , Uterine Morcellator